Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
21.26
-0.86 (-3.89%)
At close: Apr 28, 2026, 4:00 PM EDT
21.39
+0.13 (0.60%)
Pre-market: Apr 29, 2026, 8:59 AM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $16.50 billion as of April 29, 2026. Its market cap has increased by 11.00% in one year.
Market Cap
16.50B
Enterprise Value
15.81B
1-Year Change
11.00%
Ranking
Category
Stock Price
$21.26
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $16.50B, an increase of 13,765.09%. That is a compound annual growth rate of 55.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 17.15B | 31.73% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 25.81B |
| Roivant Sciences | 19.93B |
| Moderna | 19.31B |
| Incyte | 19.05B |
| Genmab | 16.46B |
| BridgeBio Pharma | 14.45B |
| Ascendis Pharma | 14.00B |
| Jazz Pharmaceuticals | 12.39B |